Using imaging to predict breast cancer type
Part of Cancer, Skin clinical trials.
This study uses ultrasound and mammogram images to try to predict the molecular type of breast cancer without needing a biopsy. If it works, it could help doctors choose the most effective treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer based on a biopsy.
- Your imaging (mammogram or ultrasound) shows a BI-RADS score of 4, 5, or 6 — meaning the finding is suspicious or already known to be cancer.
- You have not been treated with chemotherapy or hormone therapy before surgery for this cancer (no neoadjuvant therapy).
- You have not had breast cancer in the same breast before that has come back.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at breast cancer images to see whether computer-extracted patterns (“radiomics”) can help improve understanding of the disease. You may be included if your breast cancer diagnosis is confirmed and your medical records are complete.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This study uses a special ultrasound technique (VisR) to look at the structure of breast tissue and collagen in women with suspicious or known breast cancer. The goal is to see if this imaging can help doctors better understand breast cancer without needing a biopsy.
This study uses special ultrasound imaging (and may use MRI results) to look for early signs of how locally advanced breast cancer responds to chemotherapy, with or without radiation. If the imaging changes early, it could help doctors adjust treatment sooner.
This study explores a new way to process ultrasound images of the breast. It is for women who have a finding, cyst, mass, or calcifications seen on a mammogram or ultrasound, and it uses a special ultrasound technique that may provide clearer images without extra radiation.
This study tests whether an artificial intelligence (AI) system can better find the small markers placed during breast biopsies using ultrasound images. It may help improve how these markers are detected in the future.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.